Literature DB >> 33410384

Case series of acute peritoneal dialysis in the prone position for acute kidney injury during the Covid-19 pandemic: Prone to complications?

Qandeel H Soomro1, Vikramjit Mukherjee2, Richard Amerling3, Nina Caplin1.   

Abstract

Patients with kidney failure and acute respiratory distress syndrome (ARDS) requiring prone position have not been candidates for peritoneal dialysis (PD) due to concern with increased intra-abdominal pressure, reduction in respiratory system compliance and risks of peritoneal fluid leaks. We describe our experience in delivering acute PD during the surge in Covid-19 acute kidney injury (AKI) in the subset of patients requiring prone positioning. All seven patients included in this report were admitted to the intensive care unit with SARS-CoV-2 infection leading to ARDS, AKI and multisystem organ failure. All required renal replacement therapy, and prone positioning to improve ventilation/perfusion mismatch. All seven were able to continue PD despite prone positioning without any detrimental effects on respiratory mechanics or the need to switch to a different modality. Fluid leakage was noted in 71% of patients, but mild and readily resolved. We were able to successfully implement acute PD in ventilator-dependent prone patients suffering from Covid-19-related AKI. This required a team effort and some modifications in the conventional PD prescription and delivery.

Entities:  

Keywords:  AKI; ARDS; Acute peritoneal dialysis; Covid; ICU; renal failure

Year:  2021        PMID: 33410384     DOI: 10.1177/0896860820983670

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  2 in total

Review 1.  Peritoneal Dialysis as a Renal Replacement Therapy Modality for Patients with Acute Kidney Injury.

Authors:  Sana Farooq Khan
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

Review 2.  Epidemiology, prognosis and management of potassium disorders in Covid-19.

Authors:  Maryam Noori; Seyed A Nejadghaderi; Mark J M Sullman; Kristin Carson-Chahhoud; Ali-Asghar Kolahi; Saeid Safiri
Journal:  Rev Med Virol       Date:  2021-06-02       Impact factor: 11.043

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.